Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Amigal
Amigal
Amicus' 'Transformative' Changes Look More Like Big Step Backward
Amicus' 'Transformative' Changes Look More Like Big Step Backward
TheStreet.com
Amicus Therapeutics
GSK
Sanofi
Biomarin
Callidus Biopharma
Amigal
Flag link:
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
Amicus Delays U.S. Approval Filing for Fabry Disease Drug
TheStreet.com
Fabry's disease
Amicus
GSK
Amigal
Flag link:
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Flag link:
A Legit Reason To Give Amicus' Fabry Drug Another Chance
A Legit Reason To Give Amicus' Fabry Drug Another Chance
TheStreet.com
Amicus
Fabry's disease
Amigal
Flag link:
Amicus Fabry Drug Fails Pivotal Trial
Amicus Fabry Drug Fails Pivotal Trial
TheStreet.com
Amicus
Fabry's disease
Amigal
GSK
Flag link:
Amicus Soon To Release New Phase III Data
Amicus Soon To Release New Phase III Data
Seeking Alpha
Amicus
AT1001
Amigal
Migalastat HCl
Fabry's disease
Flag link:
Amicus: Bullish Options Trade Into Clinical Trial Catalysts
Amicus: Bullish Options Trade Into Clinical Trial Catalysts
TheStreet.com
Amicus
clinical trials
Amigal
Flag link:
Amicus Therapeutics Poised For Rebound Into December Phase III Results
Amicus Therapeutics Poised For Rebound Into December Phase III Results
Seeking Alpha
Amicus Therapeutics
GSK
Amigal
Flag link:
GlaxoSmithKline licenses Amicus drug in $230M deal
GlaxoSmithKline licenses Amicus drug in $230M deal
Bizjournals.com
Amicus Therapeutics
GSK
licensing
Amigal
Fabry's disease
Flag link: